MENU
LFMDP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

LFMDP stock forecast, quote, news & analysis

LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
LFMDP
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for LFMDP with price predictions
Oct 09, 2026

LFMDP in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 06, 2026

LFMDP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 18 of 38 cases where LFMDP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 47%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +0.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFMDP advanced for three days, in 93 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 42%.

Bearish Trend Analysis

The 10-day RSI Indicator for LFMDP moved out of overbought territory on September 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 16 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 65 cases where LFMDP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFMDP as a result. In 56 of 123 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.

The Moving Average Convergence Divergence Histogram (MACD) for LFMDP turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 25 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 46%.

LFMDP moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFMDP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.

The Aroon Indicator for LFMDP entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.432). LFMDP has a moderately low P/E Ratio (0.000) as compared to the industry average of (46.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). LFMDP's Dividend Yield (0.096) is considerably higher than the industry average of (0.010). P/S Ratio (0.000) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating fairly steady price growth. LFMDP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFMDP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

A.I.Advisor
published Dividends

LFMDP is expected to pay dividends on October 15, 2026

LifeMD LFMDP Stock Dividends
A quarterly dividend of $0.55 per share will be paid with a record date of October 15, 2026, and an ex-dividend date of October 02, 2026. The last dividend of $0.55 was paid on July 15. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.95B. The market cap for tickers in the group ranges from 708 to 45.33B. VEEV holds the highest valuation in this group at 45.33B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -0%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 31%. EVH experienced the highest price growth at 17%, while MNDR experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 23% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 74
Price Growth Rating: 52
SMR Rating: 86
Profit Risk Rating: 97
Seasonality Score: 5 (-100 ... +100)
LFMDP in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 06, 2026